Drug profile · INN
quinidine sulfate
QUINIDINE SULFATE
quinidine sulfate (QUINIDINE SULFATE) is a sodium channel alpha subunit blocker. Associated with BICYCLE THERAPEUTICS. Route of administration: oral. Current US regulatory status: approved.
Drug details — quinidine sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
quinidine sulfate (QUINIDINE SULFATE) is a sodium channel alpha subunit blocker. Associated with BICYCLE THERAPEUTICS. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is quinidine sulfate?
quinidine sulfate (QUINIDINE SULFATE) is a sodium channel alpha subunit blocker. Associated with BICYCLE THERAPEUTICS. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for quinidine sulfate?
QUINIDINE SULFATE is a marketed brand name for quinidine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of quinidine sulfate?
quinidine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.